Fresenius Medical Care Announces Encouraging Results Of CALMAG Study On Phosphate Binder OsvaRen® At The 2010 EDTA …

Published July 23, 2010

Fresenius Medical Care Announces Encouraging Results Of CALMAG Study On Phosphate Binder OsvaRen® At The 2010 EDTA …
Based on data from its recently completed CALMAG (CALcium acetate MAGnesium carbonate evaluation) study, Fresenius Medical Care is announcing a demonstration of the effectiveness of its combined phosphate binder OsvaRen® (calcium acetate/magnesium carbonate) in the treatment of hyperphosphatemia in hemodialysis patients. A scientific symposium unveiling these findings will take place during the …
Read more on Medical News Today

By Donald Kirk
WASHINGTON – Behind brave blasts of bombast and bluster, North Korea has one urgent reason for wanting to renew six-party talks on its nuclear program and separate meetings with an American general at the truce village of Panmunjom.
Read more on Thailand Outlook Channel